Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05739227
Status:
RECRUITING
Last Update Posted:
2023-02-22
First Post:
2023-02-11
Brief Title:
Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting rr B-cell Hematologic Malignancies
Sponsor:
Xuzhou Medical University
Organization:
Xuzhou Medical University
Organization Data
Organization:
Xuzhou Medical University
Class:
OTHER
Study ID:
XYFY2022-KL252-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xuzhou Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Kai Lin XuMD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Xuzhou Medical University
Old Name:
None
Old Organization:
None